Unlock instant, AI-driven research and patent intelligence for your innovation.

Compositions

An analog, dinucleoside polyphosphate technology, applied in the field of composition, can solve problems such as uncured and uncontrollable seizures

Inactive Publication Date: 2016-11-23
GLOBALACORN
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Epilepsy can usually be controlled with medication, but it cannot be cured
However, even with the best available medications, more than 30% of people with epilepsy are unable to control their seizures

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions
  • Compositions
  • Compositions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0198] In vivo data-AppCH 2 Antiepileptic activity of ppA in a mouse model of tuberous sclerosis

[0199] Tuberous sclerosis syndrome (TSC) is caused by a dominant mutation in the TSC1 or TSC2 tumor suppressor gene and is characterized by abnormal brain damage, that is, cortical nodules that are thought to contribute to the development of drug-resistant epilepsy Section. Tsc1 heterozygotes without nodules + / - The mice showed relapse and lived in the early postnatal period ( figure 1 with figure 2 ).

[0200] When the stable synthetic dinucleoside polyphosphate analogue AppCH 2 ppA was administered to Tsc1 by intraperitoneal (i.p.) injection at a dose of 100 μM (200 μl) (20 nmol; 1000 nmol / kg or 0.84 mg / kg of animal body weight) + / - In mice, there are basically complete anti-epileptic effects ( image 3 ). When using 30μM (200μl) (6nmol; 300nmol / kg or 0.25mg / kg of animal body weight) AppCH 2 ppA dose repeat the experiment ( Figure 4 ), the effect on epilepsy is partial.

Embodiment 2

[0202] In vitro data-AppCH 2 Antiepileptic activity of ppA in mouse cortical sections

[0203] Wild type and Tsc1 + / - The mice (P14~P16) were anesthetized, and their brains were quickly removed and placed in oxygenated ice-cold saline buffer. Before recording, the sections were incubated in artificial cerebrospinal fluid (ACSF). After in vitro administration of the slices, monitor AppCH 2 The effect of ppA administration. Untreated sections were also studied for control comparison (Figure 5). Slicing work shows: AppCH 2 ppA inhibited the onset of external electrical impulses on single cortical neurons and the entire animal.

Embodiment 3

[0205] In vitro data-AppCH 2 Antiepileptic activity of ppA in mouse hippocampal slices

[0206] The slices were prepared as described previously (Melnik S, Wright M, Tanner JA, Tsintsadze T, Tsintsadze V, Miller AD, Lozovaya N (2006) Diadenosine polyphosphate analogcontrols postsynaptic excitation in CA3-CA1synapses via a nitric oxide-dependent mechanism. J Pharmacol Exp Ther 318(2):579-588.doi:10.1124 / jpet.105.097642). Add tetrandrine (100μM) to the perfusion solution and remove Mg 2+ Induce spontaneous epileptiform events lasting 5-10 seconds ( Figure 7 ). In the first few minutes after the start of tetrandrine infusion, these events initially appeared at a low rate, and the rate gradually increased to reach a plateau frequency of about 6-8 events / 5 minutes within 20-30 minutes. ). Without Mg 2+ When the extracellular fluid of tetrandrine toxin continues to exist, it bursts at such a rate for at least 2 hours. After in vitro section administration, monitor AppCH 2 The effec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
electrical resistanceaaaaaaaaaa
Login to View More

Abstract

The invention provides a dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use as an anticonvulsant and / or seizure suppressant, in particular in the treatment or prevention of (e.g. juvenile)epilepsy.

Description

Technical field [0001] The present invention relates to the use of dinucleoside polyphosphates (analogs) and other compounds as anticonvulsants and / or seizure inhibitors, more particularly for the treatment (or prevention, suppression and / or alleviation) of epilepsy, and therefore Acts as an anti-epileptic agent. Background technique [0002] Epilepsy is a common and diverse chronic neurological disorder characterized by hair. Epileptic seizures are caused by abnormal, excessive, or hypersynchronized nerve activity in the brain. Approximately 50 million people worldwide suffer from epilepsy, and nearly 80% of epilepsy occur in developing countries. As people get older, epilepsy becomes more and more common. [0003] Epilepsy can usually be controlled with medication, but it cannot be cured. However, even with the best available drugs, more than 30% of epilepsy patients cannot control their seizures. In addition, different epilepsy syndromes can correspond to different drugs, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/06A61K31/7084A61P25/08
CPCA61K31/7084A61K45/06A61P25/08A61K2300/00
Inventor 安德鲁·大卫·米勒纳塔利娅·洛佐瓦亚纳伊尔·本娜谢夫拉希德·吉尼娅图琳
Owner GLOBALACORN